Ehete Bahiru1, Anubha Agarwal2, Mark A Berendsen3, Abigail S Baldridge4, Tecla Temu5, Amy Rogers6, Carey Farquhar7, Frederick Bukachi8, Mark D Huffman2,4,9. 1. Department of Medicine, University of California Los Angeles, CA (E.B.). 2. Department of Medicine (A.A., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL. 3. Galter Health Sciences Library (M.A.B.), Northwestern University Feinberg School of Medicine, Chicago, IL. 4. Department of Preventive Medicine (A.S.B., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL. 5. Departments of Global Health (T.T.), University of Washington, Seattle. 6. Department of Medicine, Stanford University School of Medicine, Palo Alto, CA (A.R.). 7. Departments of Epidemiology and Medicine (C.F.), University of Washington, Seattle. 8. Department of Physiology, University of Nairobi, Kenya (F.B.). 9. The George Institute for Global Health, Food Policy Division, Sydney, Australia (M.D.H.).
Abstract
BACKGROUND: Quality improvement initiatives have been developed to improve acute coronary syndrome care largely in high-income country settings. We sought to synthesize the effect size and quality of evidence from randomized controlled trials (RCTs) and nonrandomized studies for hospital-based acute coronary syndrome quality improvement interventions on clinical outcomes and process of care measures for their potential implementation in low- and middle-income country settings. METHODS AND RESULTS: We conducted a bibliometric search of databases and trial registers and a hand search in 2016 and performed an updated search in May 2018 and May 2019. We performed data extraction, risk of bias assessment, and quality of evidence assessments in duplicate. We assessed differences in outcomes by study design comparing RCTs to nonrandomized quasi-experimental studies and by country income status. A meta-analysis was not feasible due to substantial, unexplained heterogeneity among the included studies, and thus, we present a qualitative synthesis. We screened 5858 records and included 32 studies (14 RCTs [n=109 763] and 18 nonrandomized quasi-experimental studies [n=54-423]). In-hospital mortality ranged from 2.1% to 4.8% in the intervention groups versus 3.3% to 5.1% in the control groups in 5 RCTs (n=55 942). Five RCTs (n=64 313) reported 3.0% to 31.0% higher rates of reperfusion for patients with ST-segment-elevation myocardial infarction in the intervention groups. The effect sizes for in-hospital and discharge medical therapies in a majority of RCTs were 3.0% to 10.0% higher in the intervention groups. There was no significant difference in 30-day mortality evaluated by 4 RCTs (n=42 384), which reported 2.5% to 15.0% versus 5.9% to 22% 30-day mortality rates in the intervention versus control groups. In contrast, nonrandomized quasi-experimental studies reported larger effect sizes compared to RCTs. There were no significant consistent differences in outcomes between high-income and middle-income countries. Low-income countries were not represented in any of the included studies. CONCLUSIONS: Hospital-based acute coronary syndrome quality improvement interventions have a modest effect on process of care measures but not on clinical outcomes with expected differences by study design. Although quality improvement programs have an ongoing and important role for acute coronary syndrome quality of care in high-income country settings, further research will help to identify key components for contextualizing and implementing such interventions to new settings to achieve their desired effects. Systematic Review Registration: URL: https://www.crd.york.ac.uk/PROSPERO/. Unique identifier: CRD42016047604.
BACKGROUND: Quality improvement initiatives have been developed to improve acute coronary syndrome care largely in high-income country settings. We sought to synthesize the effect size and quality of evidence from randomized controlled trials (RCTs) and nonrandomized studies for hospital-based acute coronary syndrome quality improvement interventions on clinical outcomes and process of care measures for their potential implementation in low- and middle-income country settings. METHODS AND RESULTS: We conducted a bibliometric search of databases and trial registers and a hand search in 2016 and performed an updated search in May 2018 and May 2019. We performed data extraction, risk of bias assessment, and quality of evidence assessments in duplicate. We assessed differences in outcomes by study design comparing RCTs to nonrandomized quasi-experimental studies and by country income status. A meta-analysis was not feasible due to substantial, unexplained heterogeneity among the included studies, and thus, we present a qualitative synthesis. We screened 5858 records and included 32 studies (14 RCTs [n=109 763] and 18 nonrandomized quasi-experimental studies [n=54-423]). In-hospital mortality ranged from 2.1% to 4.8% in the intervention groups versus 3.3% to 5.1% in the control groups in 5 RCTs (n=55 942). Five RCTs (n=64 313) reported 3.0% to 31.0% higher rates of reperfusion for patients with ST-segment-elevation myocardial infarction in the intervention groups. The effect sizes for in-hospital and discharge medical therapies in a majority of RCTs were 3.0% to 10.0% higher in the intervention groups. There was no significant difference in 30-day mortality evaluated by 4 RCTs (n=42 384), which reported 2.5% to 15.0% versus 5.9% to 22% 30-day mortality rates in the intervention versus control groups. In contrast, nonrandomized quasi-experimental studies reported larger effect sizes compared to RCTs. There were no significant consistent differences in outcomes between high-income and middle-income countries. Low-income countries were not represented in any of the included studies. CONCLUSIONS: Hospital-based acute coronary syndrome quality improvement interventions have a modest effect on process of care measures but not on clinical outcomes with expected differences by study design. Although quality improvement programs have an ongoing and important role for acute coronary syndrome quality of care in high-income country settings, further research will help to identify key components for contextualizing and implementing such interventions to new settings to achieve their desired effects. Systematic Review Registration: URL: https://www.crd.york.ac.uk/PROSPERO/. Unique identifier: CRD42016047604.
Authors: E F Ellerbeck; T F Kresowik; R A Hemann; P Mason; R T Wiblin; T A Marciniak Journal: Int J Qual Health Care Date: 2000-08 Impact factor: 2.038
Authors: Thomas C Bailey; Laura A Noirot; Amy Blickensderfer; Erin Rachmiel; Robyn Schaiff; Anthony Kessels; Alan Braverman; Anne Goldberg; Brian Waterman; W Claiborne Dunagan Journal: Arch Intern Med Date: 2007-03-26
Authors: Eta S Berner; C Suzanne Baker; Ellen Funkhouser; Gustavo R Heudebert; Jeroan J Allison; Crayton A Fargason; Qing Li; Sharina D Person; Catarina I Kiefe Journal: Med Care Date: 2003-03 Impact factor: 2.983
Authors: Ian A Scott; Charles P Denaro; Annabel C Hickey; Cameron Bennett; Alison M Mudge; Daniela C Sanders; Justine Thiele; Judy L Flores Journal: Int J Qual Health Care Date: 2004-08 Impact factor: 2.038
Authors: Julian T Hertz; Francis M Sakita; Godfrey L Kweka; Gerald S Bloomfield; John A Bartlett; Tumsifu G Tarimo; Gloria Temu; Janet P Bettger; Nathan M Thielman Journal: J Am Heart Assoc Date: 2020-08-08 Impact factor: 5.501